Clinical Trials
8
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting
- Conditions
- Lung NeoplasmsLung Cancer
- Interventions
- Drug: OTL38 for InjectionDevice: Near infrared camera imaging system
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- On Target Laboratories, LLC
- Target Recruit Count
- 112
- Registration Number
- NCT04241315
- Locations
- 🇺🇸
Stamford, Stamford, Connecticut, United States
🇺🇸University of Iowa, Iowa City, Iowa, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer
- Conditions
- Ovarian Cancer
- Interventions
- First Posted Date
- 2017-06-08
- Last Posted Date
- 2022-02-04
- Lead Sponsor
- On Target Laboratories, LLC
- Target Recruit Count
- 140
- Registration Number
- NCT03180307
- Locations
- 🇺🇸
The Mayo Clinic - Phoenix, Phoenix, Arizona, United States
🇺🇸University of Arizona, Tucson, Arizona, United States
🇺🇸City of Hope Medical Center, Duarte, California, United States
OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
- Conditions
- Lung NeoplasmsLung Cancer
- Interventions
- Drug: OTL38 for InjectionDevice: Near infrared camera imaging systemProcedure: Endoscopic or Thoracic Surgery
- First Posted Date
- 2016-08-19
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- On Target Laboratories, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT02872701
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States
Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer
- Conditions
- Ovarian Cancer
- Interventions
- First Posted Date
- 2014-12-16
- Last Posted Date
- 2022-06-21
- Lead Sponsor
- On Target Laboratories, LLC
- Target Recruit Count
- 48
- Registration Number
- NCT02317705
- Locations
- 🇺🇸
University of CA at Irvine Chao Cancer Center, Orange, California, United States
🇺🇸Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸Mayo Clinic-Rochester, Rochester, Minnesota, United States